Vasopressin in cardiovascular patients: therapeutic implications

Bibliography

• OLIVER H & SCHAFER E: On the physiological action of extracts of the pituitary body and certain other glandular organs. j Physic] (fond.) (1895) 18:277–279.
   Google Scholar
• FARINI F: Diabete insipido ed opoterapia. Gazz. Osped. Clin (1913) 34:1135–1139.
   Google Scholar
• TURNER RA, PIERCE JG & DU VIGNEAUD V: The purification and the amino acid content of vasopressin prep-aration. J. Biol. Chem. (1951) 191:21–28.
   PubMed Web of Science ®Google Scholar
• CORLEY DA, CELLO JP, ADKISSON W, KO WF & KERLIKOWSKE K: Octreotide for acute esophageal variceal bleeding: a meta-analysis. Gastroenterology (2001) 120(4):946–954.
   PubMed Web of Science ®Google Scholar
• LANDRY DW, LEVIN HR, GALLANT EM et al.: Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation (1997) 95(5):1122–1125.
   PubMed Web of Science ®Google Scholar
• •This study first identifies inappropriately low plasma vasopressin levels as a possible contributor to vasodilatory shock in sepsis.
   Google Scholar
• ARGENZIANO M, CHEN JM, CHOUDHRI AF et al.: Management of vasodilatory shock after cardiac surgery: identification of predisposing factors and use of a novel pressor agent. I Thorac. Cardiovasc. Surg. (1998) 116(6):973–980.
   PubMed Web of Science ®Google Scholar
• •This study documents the actual incidence of post- CPB vasodilatory shock (8%) and identifies independent predictors.
   Google Scholar
• REID IA: Role of vasopressin deficiency in the vasodilation of septic shock. Circulation (1997) 95(5):1108–1110.
   PubMed Web of Science ®Google Scholar
• SCHRIER RW, BERL T & ANDERSON RJ: Osmotic and nonosmotic control of vasopressin release. Am. I Physic] (1979) 236:F321–F332.
   PubMed Web of Science ®Google Scholar
• WOOD CE & CHEN HG: Acidemia stimulates ACTH, vasopressin and heart rate responses in fetal sheep. Am. j Physic] (1989) 257:R344–R349.
   Google Scholar
• SWAAB DE NIJVELDT F & POOL CW: Distribution of oxytocin and vasopressin in the rat supraoptic and paraventricular nucleus. j Endocrinol (1975) 67:461–462.
   PubMed Web of Science ®Google Scholar
• HOLMES CL, PATEL BM, RUSSELL JA& WALLEY KR: Physiology of vasopressin relevant to management of septic shock. Chest (2001) 120:989–1002.
   PubMed Web of Science ®Google Scholar
• THIBONNIER M, PRESTON JA, DULIN N et al.: The human V3 pituitary vasopressin receptor: ligand binding profile and density-dependent signalling pathways. Endocrinology (1997) 138:4109–4122.
   PubMed Web of Science ®Google Scholar
• EICHINGER MR & WALKER BR: Enhanced pulmonary arterial dilation to arginine vasopressin in chronically hypoxic rats. Am. J. Physic] (1994) 267:H2413–H2419.
   Google Scholar
• PITTMAN QJ & WILKINSON MF: Central arginine vasopressin and endogenous antipyresis. Can. j Physiol Pharmacol (1992) 70:786–790.
   PubMed Web of Science ®Google Scholar
• DORIS PA: Vasopressin and central integrative processes. Neuroendocrinology (1984) 38:75–85.
   PubMed Web of Science ®Google Scholar
• BICHET DG, RAZI M, LONERGAN M et al.: Hemodynamic and coagulation responses to 1-desamino [8-D-argininel vasopressin in patients with congenital nephrogenic diabetes insipidus. N Engl. Med. (1988) 318:881–887.
   PubMed Web of Science ®Google Scholar
• MANNUCCI PM, CANCIANI MT, ROTA L & DONOVAN BS: Response of Factor VIII/von Willebrand factor to DDAVP in healthy subjects and patients with hemophilia A and von Willebrand's disease. Br. J. Haematol (1981) 47:283–293.
   PubMed Web of Science ®Google Scholar
• WEIG HJ, LAUGWITZ KL, MORETTI A et al.: Enhanced cardiac contractility after gene transfer of V2 vasopressin receptors in vivo by ultrasound-guided injection or transcoronary delivery. Circulation (2000) 101:1578–1575.
   PubMed Web of Science ®Google Scholar
• STUMP DL & HARDIN TC: The use of vasopressin in the treatment of upper gastrointestinal hemorrhage. Drugs (1990) 39(1):38–53.
   PubMed Web of Science ®Google Scholar
• KEY DW, BLOOM DA & SAN VORDENKER J: Low-dose DDAVP in nocturnal enuresis. Clin Pediatr. (Phila.) (1992) 31(5):299–301.
   PubMed Web of Science ®Google Scholar
• COWLEY AW, CUSHMAN WC, QUILLEN EW, SKELTON MM & LANGFORD HG: Vasopressin elevation in essential hypertension and increased responsiveness to sodium intake.Hypertension (1981) 3:193–1100.
   Web of Science ®Google Scholar
• MORTON JJ, PADFIELD PL & FORSLING ML: A radioimmunoassay for plasma arginine-vasopressin in man and dog: application to physiological and pathological states. j Endocrinol (1975) 65:411–424.
   PubMed Web of Science ®Google Scholar
• WU W, ZBUZEK VK & BELLEVUE C: Vasopressin release during cardiac operation. j Thorac. Cardiovasc. Surg. (1980) 79(1):83–90.
   PubMed Web of Science ®Google Scholar
• LEVINE FH, PHILBIN DM, KONO K et al.: Plasma vasopressin levels and urinary sodium excretion during cardiopulmonary bypass with and without pulsatile flow. Ann. Thorac. Surg. (1981) 32(1):63–67.
   PubMed Web of Science ®Google Scholar
• WOODS WG, FORSLING ML & LE QUESNE LP: Plasma arginine vasopressin levels and arterial pressure during open heart surgery. Br. J. Surg. (1989) 76(1):29–32.
   PubMed Web of Science ®Google Scholar
• MALAY MB, ASHTON RC JR, LANDRY DW & TOWNSEND RN: Low-dose vasopressin in the treatment of vasodilatory septic shock. j Trauma. (1999) 47(4):699–703.
   PubMed Web of Science ®Google Scholar
• TSUNEYOSHI I, YAMADA H, KAKIHANA Y etal.: Hemodynamic and metabolic effects of low-dose vasopressin infusions in vasodilatory septic shock. Crit. Care Med. (2001) 29 (3):487–493.
   Google Scholar
• TRACKER U, GEARY V, CHALMERS P & SHEIKH F: Low systemic vascular resistance during cardiac surgery: case reports, brief review and management with angiotensin II. j Cardiothorac. Arresth. (1990) 4:360–363.
   PubMedGoogle Scholar
• EGENER TH, COMUNALE ME & LECKIE RS: The use of a somatostatin analog in the treatment of refractory hypotension after cardiopulmonary bypass. Cardiothorac. Vasc. Arresth. (1992) 6(4):458–460.
   PubMedGoogle Scholar
• ARGENZIANO M, CHOUDHRI AF, OZ MC et al.: A prospective randomized trial of arginine vasopressin in the treatment of vasodilatory shock after left ventricular assist device placement. Circulation (1997) 96(9,
   PubMed Web of Science ®Google Scholar
• ••This is the only prospective, randomised study to date which attempts to characterise the role of vasopressin in patients with documented vasopressin-deficiency post-CPB.
   Google Scholar
• MORALES DL, GREGG D, HELMAN DN et al.: Arginine vasopressin in the treatment of 50 patients with postcardiotomy vasodilatory shock. Ann. Thorac. Surg. (2000) 69(1):102–106.
   PubMed Web of Science ®Google Scholar
• ROSENZWEIG EB, STARC TJ, CHEN JM et al.: Intravenous arginine-vasopressin in children with vasodilatory shock after cardiac surgery. Circulation (1999) 100(19, Suppl.):11182–186.
   Google Scholar
• ARGENZIANO M, CHEN JM, CULLINANE S et al: Arginine vasopressin in the management of vasodilatory hypotension after cardiac transplantation. Heart Lung Transplant. (1999) 18(8):814–817.
   PubMed Web of Science ®Google Scholar
• LINDNER KH, DIRKS B, STROHMENGER HU et al: Randomised comparison of adrenaline and vasopressin in patients with out-of-hospital ventricular fibrillation. Lancet. (1997) 349(9051):535–537.
   PubMed Web of Science ®Google Scholar
• •A randomised study comparing vasopressin to adrenaline. The authors demonstrate a higher success rate in resuscitation of out-of-hospital ventricular fibrillation with 40 U of vasopressin.
   Google Scholar
• WOODHOUSE SP, COX S, BOYD P, CASE C & WEBER M: High dose and standard dose adrenaline do not alter survival, compared with placebo, in cardiac arrest. Resuscitation (1995) 30(3):243–249.
   PubMed Web of Science ®Google Scholar
• LINDNER KH, AHNEFELD FW, SCHUERMANN W & BOWDLER IM: Adrenaline and noradrenaline in cardiopulmonary resuscitation. Effects on myocardial oxygen delivery and consumption. Chest (1990) 97(6):1458–1462.
   Google Scholar
• DITCHEY RV & LINDENFELD J: Failure of adrenaline to improve the balance between myocardial oxygen supply and demand during closed-chest resuscitation in dogs. Circulation (1988) 78(2):382–389.
   PubMedGoogle Scholar
• LINDNER KH, PRENGEL AW, PFENNINGER EG et al.: Vasopressin improves vital organ blood flow during closed-chest cardiopulmonary resuscitation in pigs. Circulation (1995) 91(1):215–221.
   PubMed Web of Science ®Google Scholar
• PRENGEL AW, LINDNER KH & KELLER A: Cerebral oxygenation during cardiopulmonary resuscitation with adrenaline and vasopressin in pigs. Stroke (1996) 27(7):1241–1248.
   PubMed Web of Science ®Google Scholar
• VOELCKEL WG, LURIE KG, LINDNER KH et al.: Vasopressin improves survival after cardiac arrest in hypovolemic shock. Arresth. Arralg. (2000) 91(3):627–634.
   PubMed Web of Science ®Google Scholar
• WENZEL V, LINDNER KH, KRISMER AC et al.: Survival with full neurologic recovery and no cerebral pathology after prolonged cardiopulmonary resuscitation with vasopressin in pigs. J. Am. Coll. Cardiol (2000) 35:527–523.
   PubMed Web of Science ®Google Scholar
• WENZEL V, LINDNER KH, KRISMER AC et al.: Repeated administration of vasopressin but not adrenaline maintains coronary perfusion pressure after early and late administration during prolonged cardiopulmonary resuscitation in pigs. Circulation (1999) 99(10):1379–1384.
   PubMed Web of Science ®Google Scholar
• WENZEL V, LINDNER KH & BAUBIN MA: Vasopressin decreases endogenous catecholamine plasma concentrations during cardiopulmonary resuscitation in pigs. Grit. Care Med. (2000) 28:1096–1100.
   PubMed Web of Science ®Google Scholar
• MULLIGAN KA, MCKNITE SH, LINDNER KH et al.: Synergistic effects of vasopressin plus adrenaline during cardiopulmonary resuscitation. Resuscitation (1997) 35:265–271.
   PubMed Web of Science ®Google Scholar
• LINDNER KH, HAAK T, KELLER A, BOTHNER U, LURIE KG: Release of endogenous vasopressors during and after cardiopulmonary resuscitation. Heart (1996) 75(2):145–150.
   PubMed Web of Science ®Google Scholar
• MORRIS DC, DERECZYK BE, GRZYBOWSKI M et al.: Vasopressin can increase coronary perfusion pressure during human cardiopulmonary resuscitation. Acad. Emerg. Med. (1997) 4(9):878–883.
   PubMed Web of Science ®Google Scholar
• LINDNER KH, PRENGEL AW, BRINKMANN A etal.: Vasopressin administration in refractory cardiac arrest. Ann. Intern. Med. (1996) 124(12):1061–1064.
   Google Scholar
• STIELL IG, HERBERT PC, WELLS GA et al.: Vasopressin versus adrenaline for inhospital cardiac arrest: a randomised controlled trial. Lancet. (2001) 358:105–109.
   PubMed Web of Science ®Google Scholar
• ••This is the largest randomised study incardiac arrest (in-hospital) revealing no difference in overall survival or neurological function in patients treated initially with vasopressin versus adrenaline.
   Google Scholar
• ERICSSON BF: Effect of vasopressin on the distribution of cardiac output and organ blood flow in the anesthetized dog. Acta Chic Scam/. (1971) 137:729–738.
   PubMedGoogle Scholar
• WAKIM KG, DENTON C & ESSEX HE: Certain cardiovascular effects of vasopressin (pitressin). Am. Heart J. (1953):77–83.
   PubMed Web of Science ®Google Scholar
• PRENGEL AW, LINDNER KH, KELLER A et al.: Cardiovascular function during the postresucitation phase after cardiac arrest in pigs. Crit. Care Med. (1996) 24:2014–2019.
   PubMed Web of Science ®Google Scholar
• ERICSSON BF: Hemodynamic effects of vasopressin during haemorrhagic hypotension in the anesthetized dog. Acta Chic Scam/. (1972) 138:227–233.
   PubMedGoogle Scholar
• LINDNER KH, BRINKMANN A, PFENNINGER EG et al.: Effect of vasopressin on hemodynamic variables, organ blood flow and acid-base status in a pig model of cardiopulmonary resuscitation. Arresth. Arralg. (1993) 77:427–435.
   PubMed Web of Science ®Google Scholar
• LUCE J, RIZK N & NISKANEN R: Regional blood flow during cardiopulmonary resuscitation in dogs. Grit. Care Med(1984) 12:874–878.
   PubMed Web of Science ®Google Scholar
• WENZEL V & LINDNER KH: Employing vasopressin during cardiopulmonary resuscitation and vasodilatory shock as a lifesaving vasopressor. Cardiovasc. Res. (2001) 51:529–541.
   PubMed Web of Science ®Google Scholar
• DUNSER MW, MAYR AJ, ULMER H et al.: The effects of vasopressin on systemic hemodynamics in catecholamine-resistant septic and postcardiotomy shock: A retrospective analysis. Arresth. Arralg. (2001) 93:7–13.
   PubMed Web of Science ®Google Scholar
• International consensus on science, American Heart Association: guidelines 2000 for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation (2000) 102(Suppl.):I1–1384.
   Google Scholar
• Guidelines 2000 for cardiopulmonary resuscitation and emergency cardiovascular care. International consensus on science. Resuscitation (2000) 46:1–447.
   Google Scholar
• KERN KB, HALPERIN HR & FIELD J: New guidelines for cardiopulmonary resuscitation and emergency cardiac care: changes in the management of cardiac arrest. JAMA (2001) 285:1267–1269.
   PubMed Web of Science ®Google Scholar